SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-029036
Filing Date
2024-09-12
Accepted
2024-09-12 13:50:15
Documents
1
Period of Report
2024-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5214
  Complete submission text file 0001437749-24-029036.txt   6630
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O UROGEN PHARMA, LTD. 400 ALEXANDER PARK DRIVE, 4TH FLOOR PRINCETON NJ 08540
Business Address
Kim Dong (Reporting) CIK: 0001920163 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38079 | Film No.: 241294535